Dr. Christopher John

Professional Summary

Dr. Christopher John is a dedicated Radiation Oncology specialist holding an M.B.B.S. and M.D. in Radiotherapy. He currently serves as a Visiting Consultant in Radiation Oncology at the Cancer Centre of Rela Hospital, Chennai, one of India's leading tertiary care institutions. With specialized training in advanced radiation techniques, Dr. John brings focused expertise in treating complex cancer cases with precision and compassion. Dr. John's clinical practice centers on neuro-oncology and head and neck oncology, where he employs cutting-edge radiation delivery techniques including Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT). His research portfolio, featuring multiple PubMed-indexed publications, reflects his commitment to advancing evidence-based cancer care. International patients seeking high-quality, technologically advanced radiation treatment will find in Dr. John a physician who combines clinical precision with a patient-centered approach to oncology care.

Specializations

• Radiation Oncology
• Medical Oncology (supportive role in multidisciplinary cancer care)

Procedures & Expertise

• Radiation Therapy for Cancer
• Stereotactic Radiosurgery (SRS)
• Stereotactic Body Radiation Therapy
• Image-Guided Radiation Therapy (IMRT)
• Brachytherapy
• CyberKnife Radiosurgery

Education & Qualifications

• M.B.B.S. (2006–2012) – Chettinad Hospital and Research Institute, Kelambakkam University, The Tamil Nadu Dr. MGR Medical University
• M.D. Radiotherapy (2013–2016) – Vydehi Institute of Medical Sciences and Research Centre University, Rajiv Gandhi Institute of Health Science, Karnataka

Hospital Affiliations

• Rela Hospital (Rela MS), Chennai – Cancer Centre, Radiation Oncology Department

Affiliations & Memberships

• Association of Radiation Oncologist of India (AROI)
• European Society for Radiotherapy and Oncology (ESTRO)

Research & Publications

• Prognostic significance of metabolic tumour volume and maximum standard uptake value of fluor-18-fluorodeoxyglucose positron emission tomography with computed tomography in nasopharyngeal carcinoma. John C, et al. Contemp Oncol (Pozn). 2021;25(3):153–159. (PubMed Indexed)
• Concurrent Taxol-Based Doublet Chemotherapy as an Alternative for Intracavitary Brachytherapy Boost in Locally Advanced Carcinoma Cervix – Retrospective Analysis From a Tertiary Care Center. John C, et al. Cureus. 2021 Jul 11;13(7). (PubMed Indexed)
• Therapeutic Benefit of Placentrex in the Management of Acute Chemo Radiation Induced Mucositis in Oral Cancer Patients. Asian Pac J Cancer Prev. 2018;19(11):3099–3103. (PubMed Indexed)